HIV / AIDS in the News

Nine million people globally lack access to life-saving HIV treatment: WHO - The New Indian Express

 

Probiotic-derived bioactive metabolite reverses gut dysfunction and boosts HIV treatment response - UC Davis Health

 

Fiji Has The World’s Fastest Growing HIV Epidemic – And It Is Struggling - Health Policy Watch

 

Millions still get this wrong about HIV: Doctor explains exactly how the virus spreads, and how it doesn't - The Times of India

 

Islatravir-ulonivirine, another combination pill that could put HIV treatment on a weekly schedule | AIDS 2026 - Managed Healthcare Executive

 

Atlanta HIV rates remain unacceptably high amid federal funding shift - fox5atlanta.com

 

Atlanta HIV rates remain 'unacceptably high' amid federal funding shift - FOX 5 Atlanta

 

Adjusting To A Post-PEPFAR World - Health Policy Watch

 

Evolution of Biological Information: HIV Evolution - Science and Culture Today

 

[Press release] Cabenuva demonstrates superiority to daily oral therapy in adolescents living with HIV, as ViiV Healthcare highlights new long-acting injectable data at AIDS 2026 - European AIDS Treatment Group

 

[AIDS 2026] [Press release] ViiV Healthcare: New European, community co-created survey reveals strong interest in long-acting HIV treatment options but reported in-clinic conversations lag behind - European AIDS Treatment Group

 

AVAC: Innovation without access is injustice: AIDS 2026 opens in Rio - European AIDS Treatment Group

 

Weight-loss peptide only approved for use in HIV patients - AFP Fact Check

 

Macon town hall explains new Georgia HIV prevention law - 41NBC News

 

Review: Poignant 'In the Continuum' finds common ground in two Black women's HIV diagnoses, an ocean apart - Evanston RoundTable

 

Who's Paying the Price for Trump's Medicaid Cuts? Communities of Color and People Living With HIV. - Ms. Magazine

 

Protecting access to HIV care in a time of disruption - Unitaid

 

[AIDS 2026] aidsmap: Monthly PrEP pill could be made for US$3 a year, but Latin America is shut out of generic licensing - European AIDS Treatment Group

 

[AIDS 2026] Countries in Latin America and the Caribbean helped build the future of HIV prevention. But will they be able to benefit from it? - European AIDS Treatment Group

 

Once-weekly oral tablet proves highly effective for HIV care - News-Medical

 

Historic Funding Drop Threatens Global HIV Progress - Infectious Disease Special Edition

 

Idvynso Maintains Suppression Despite Archived Resistance Mutations - Infectious Disease Special Edition

 

Meet the Ohio nun who has been working on the frontlines of HIV/AIDS work for decades - The Buckeye Flame

 

Long-acting Cabenuva beats daily oral HIV therapy in adolescents | AIDS 2026 - Managed Healthcare Executive

 

Over 7,000 Students Aged 18-25 Test HIV Positive In Karnataka: Why The State Govt Is Conducting Mandatory H - News18

 

Hepatitis B Virus Vaccines Underperform in People Living With HIV - The American Journal of Managed Care

 

Raphael Landovitz, M.D., on HIV prevention gains, gaps | AIDS 2026 - Managed Healthcare Executive

 

Water insecurity nearly quadruples odds of poor HIV outcomes, while hunger and partner violence compound risk in East Africa - Aidsmap

 

‘It’s Like Jenga’: Ohio advocates warn federal funding cuts will undermine HIV prevention - Cleveland.com

 

Cabenuva demonstrates superiority to daily oral therapy in adolescents living with HIV, as ViiV Healthcare highlights new long-acting injectable data at AIDS 2026 - GSK